Z8C-52705-82910
1 vaccination
4 coded responses
9 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 972 / OR
- Registered
- 2021-02-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-21
Registered in v-safe
-
2021-02-21
Dose 1 — Pfizer-BioNTech
- 2021-02-21
- 2021-02-22
-
2021-02-23
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-24
-
2021-02-25
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Fair · Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-28
-
2021-03-07
Survey response — day 14, dose 1MedDRA: Immunisation reaction — Feeling: Fair · Be unable to do your normal daily activitiesFree text: COVID toesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-26
Survey response — 6 months, dose 1MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Pregnant. Morning sickness.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-02-21
Survey response — 12 months, dose 1MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I had COVID in early January.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-21
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-02-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-21 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-21 | Unsuccessful |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Dizziness
Release 5 — day 14, dose 1
Symptoms: COVID toes
Release 9 — 6 months, dose 1
Symptoms: Pregnant. Morning sickness.
Release 11 — 12 months, dose 1
Symptoms: I had COVID in early January.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Immunisation reaction | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release